Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogen-Bond-Directed Assembly of Polyanionic Cluster [Mo<sub>2</sub>O<sub>5</sub>(IO<sub>3</sub>)<sub>4</sub>]<sup>2-</sup> for Nonlinear Optical Crystal Design.

Inorganic chemistry·2026
Same author

PM<sub>2.5</sub>-bound organophosphate esters and childhood attention-deficit hyperactivity disorder symptoms: A population-based study from China.

Neurotoxicology·2026
Same author

Exposure to Per- and Polyfluoroalkyl Substances and the Risk of Sarcopenia: The Mediating Role of Serum Albumin.

Toxics·2026
Same author

A gene therapy strategy for Deoxyhypusine Synthase (DHPS) syndrome.

Research square·2026
Same author

Authentication of Linderae Radix through plant metabolomics coupled with a machine learning-enhanced <i>in situ</i> hyperspectral imaging approach.

Journal of pharmaceutical analysis·2026
Same author

Hereditary PCOS and the environmental toxicant F-53B converge on lipid metabolic reprogramming to impair fetal brain development.

Ecotoxicology and environmental safety·2026

Related Experiment Video

Updated: May 11, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.8K

Primate Model Carrying LMNA Mutation Develops Dilated Cardiomyopathy.

Xiang Luo1,2,3, Hao Jia4, Fang Wang1,2

  • 1State Key Laboratory of Primate Biomedical Research, Institute of Primate Translational Medicine, Kunming University of Science and Technology, Kunming, Yunnan, China.

JACC. Basic to Translational Science
|April 1, 2024
PubMed
Summary
This summary is machine-generated.

Researchers created a lamin A/C (LMNA)-mutated primate model to study dilated cardiomyopathy (LMD). This model accurately replicates human LMD phenotypes and disease progression, offering a valuable tool for research.

Keywords:
CRISPR-mediated adenine base editingdilated cardiomyopathylamin A/ Cprimate model

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.1K

Related Experiment Videos

Last Updated: May 11, 2026

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish
08:09

A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish

Published on: June 7, 2018

9.8K
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

4.6K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.1K

Area of Science:

  • Cardiology
  • Genetics
  • Primate Models

Background:

  • Dilated cardiomyopathy (DCM) poses clinical challenges, particularly when caused by lamin A/C (LMNA) mutations.
  • Understanding the unique phenotype of LMNA-mutated DCM (LMD) is crucial for effective treatment.

Purpose of the Study:

  • To develop a reliable primate model for LMNA-mutated dilated cardiomyopathy (LMD).
  • To characterize the phenotype and natural history of this novel primate model.
  • To facilitate research into LMD and potential therapeutic strategies.

Main Methods:

  • Development of an LMNA c.357-2A>G mutation in a primate model.
  • Comparative clinical data analysis of LMD, TTN-mutated DCM, and mutation-free DCM patients.
  • Longitudinal observation of the primate model over 48 months.
  • Comprehensive data collection including echocardiography, electrophysiology, histology, and transcriptomics.

Main Results:

  • The developed LMNA-mutated primate model closely mimics the clinical phenotype of human LMD.
  • The model exhibits a natural history consistent with human LMD progression.
  • Distinctive phenotypic features of LMD were identified through comparative analysis.

Conclusions:

  • The LMNA-mutated primate model serves as a highly relevant preclinical tool for studying LMD.
  • This model offers a unique opportunity to investigate disease mechanisms and test interventions for LMD.
  • The findings advance the understanding of LMNA-related cardiomyopathies.